Navigation Links
MedQuist Announces Resolution of SEC Investigation

MOUNT LAUREL, N.J., March 13 /PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ), a leading provider of medical transcription services, is pleased to announce that it has resolved the investigation by the Securities and Exchange Commission (SEC) regarding the Company's historic billing practices. Pursuant to the settlement, the Company agreed to the entry of final judgment in prospective litigation by the SEC, including an injunction against the Company from violating federal securities laws. Under the settlement, the Company will not pay any fines or penalties to the SEC, and the Company does not admit to or deny any liability or wrongdoing.

As originally reported by MedQuist in 2004, the SEC opened an investigation regarding the Company's historic billing practices after the Company announced it had undertaken an internal review of its billing practices and was delaying the filing of its annual report on Form 10-K for the year ended December 31, 2003. MedQuist cooperated fully with the SEC investigation and is pleased to conclude this matter.

Resolution of the SEC investigation follows the Company's resolution of the previously disclosed Department of Justice investigation, the previously disclosed settlements reached in the South Broward customer class action, the consolidated medical transcriptionist class action, and the Steiner shareholder class action lawsuits, and dismissal with prejudice of the Kanter shareholder derivative class action. Upon court approval and entry of final judgment in the SEC matter and medical transcriptionist litigation, the Company will have completely resolved all class action litigation and governmental investigation matters arising from the internal review of its historic billing practices.

About MedQuist:

MedQuist is a leading provider of medical transcription services, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions -- including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors -- help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit

"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE MedQuist Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MedQuist Reports Fourth Quarter and Year End 2008 Results
2. MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits
3. New Jersey-Based MedQuist Pays U.S. $6.6 Million to Resolve False Claims Act Allegations
4. MedQuist and Primordial to Demonstrate Integrated Applications at RSNA
5. MedQuist and Clario Form Partnership to Integrate zVision Radiology Practice Management Software with SpeechQ for Radiology
6. MedQuist Introduces SpeechQ for Radiology Integrated with RadWorkFlow
7. MedQuist Reports Third Quarter 2008 Results
8. MedQuist Reports Second Quarter 2008 Results
9. MedQuist Announces Changes to Board of Directors
10. MedQuist Announces Declaration of $2.75 per share Dividend on Common Stock
11. Award-Winning Massachusetts Hospital Selects MedQuist Enterprise Technology for Clinical Documentation and Speech Recognition
Post Your Comments:
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, ... a medical article to the newly revamped Cosmetic Town journal section, ... hair transplant procedure known as Follicular Unit Extraction (FUE). , Dr. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... of Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite ... program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/22/2017)... Sept. 22, 2017 AVACEN Medical (AVACEN) announced ... now successfully helping those with the widespread pain associated ... diagnosed Amanda in Essex, England ... my hair, experiencing no sleep at all, tremendous pain, ... I cannot recommend [the AVACEN 100] enough, how this ...
Breaking Medicine Technology: